MIRAE ASSET
MIDCAP FUND - (MAMCF)

(Midacap Fund - An open ended equity scheme predominantly investing in mid cap stocks)
Details as on June 30, 2023
Type of Scheme An open ended equity scheme predominantly investing in mid cap stocks
Investment Objective The investment objective of the scheme is to provide long-term capital appreciation from a portfolio investing predominantly in Indian equity and equity related securities of midcap companies. From time to time, the fund manager may also participate in other Indian equities and equity related securities for optimal portfolio construction. There is no assurance that the investment objective of the Scheme will be realized.
Fund Manager**
Mr. Ankit Jain (since inception)
Allotment Date 29th July, 2019
Benchmark Index Nifty Midcap 150 (TRI)
Minimum Investment
Amount
₹ 5,000/- and in multiples of ₹ 1/-thereafter. Minimum Additional Application Amount: ₹ 1,000/- per application and in multiples of ₹ 1/- thereafter.
Systematic Investment
Plan (SIP)
(Any Date SIP is available from 1st July, 2019)
Monthly and Quarterly: ₹1,000/- (multiples of ₹1/- thereafter), minimum 5 in case of Monthly or 3 in case of Quarterly option.
Load Structure Entry load: NA
Exit load: If redeemed within 1 year (365 days) from the date of allotment: 1%. If redeemed after 1 year (365 days) from the date of allotment: NIL
Plans Available Regular Plan and Direct Plan
Options Available Growth Option and IDCW Option (Payout & Re-investment)
Monthly Average AUM (₹ Cr.) as on June 30, 2023 10,148.78
Net AUM
(₹ Cr.)
10,567.13
Monthly Avg. Expense Ratio
(Including Statutory Levies)
as on June 30, 2023
Regular Plan: 1.73%
Direct Plan: 0.62%
**For experience of Fund Managers Click Here
NAV: Direct Regular
Growth ₹ 24.954 ₹ 23.592
IDCW ₹ 21.017 ₹ 19.745
New Position Bought
Stock
Capital Markets
HDFC Asset Management Company Limited
Industrial Manufacturing
Tega Industries Limited
Insurance
Star Health And Allied Insurance Company Limited
Retailing
FSN E-Commerce Ventures Limited
Positions Increased
Stock
Banks
Indian Bank
State Bank of India
Consumer Durables
Bata India Limited
Century Plyboards (India) Limited
Crompton Greaves Consumer Electricals Limited
Finance
LIC Housing Finance Limited
Gas
Indraprastha Gas Limited
Pharmaceuticals & Biotechnology
Lupin Limited
Realty
Prestige Estates Projects Limited
Telecom - Services
Tata Communications Limited
Transport Services
Delhivery Limited
Positions Decreased
Stock
Aerospace & Defense
Bharat Electronics Limited
Auto Components
Craftsman Automation Limited
Automobiles
TVS Motor Company Limited
Banks
Axis Bank Limited
The Federal Bank Limited
Capital Markets
UTI Asset Management Company Limited
Cement & Cement Products
Nuvoco Vistas Corporation Limited
Consumer Durables
Voltas Limited
Electrical Equipment
Thermax Limited
Ferrous Metals
Jindal Steel & Power Limited
Finance
Power Finance Corporation Limited
Shriram Finance Limited
Healthcare Services
Krishna Institute Of Medical Sciences Limited
Industrial Products
Bharat Forge Limited
Insurance
Max Financial Services Limited
Pharmaceuticals & Biotechnology
Ajanta Pharma Limited
Natco Pharma Limited

Portfolio Holdings % Allocation
Consumer Durables  
Bata India Limited 2.32%
Crompton Greaves Consumer Electricals Limited 2.26%
Kajaria Ceramics Ltd 2.17%
Century Plyboards (India) Limited 1.19%
Voltas Ltd 0.85%
Dixon Technologies (India) Limited 0.56%
Banks  
The Federal Bank Limited 3.31%
Axis Bank Ltd 2.67%
State Bank of India 2.25%
Indian Bank 1.09%
Pharmaceuticals & Biotechnology  
Lupin Limited 2.43%
Biocon Ltd 1.36%
Natco Pharma Limited 1.26%
Laurus Labs Limited 1.21%
IPCA Laboratories Limited 0.97%
Ajanta Pharma Ltd 0.97%
Industrial Products  
Bharat Forge Limited 3.24%
SKF India Limited 2.72%
Prince Pipes And Fittings Limited 1.38%
Finance  
Shriram Finance Limited 3.26%
Power Finance Corporation Ltd 2.27%
LIC Housing Finance Limited 0.90%
IT - Software  
LTIMindtree Limited 2.20%
Coforge Limited 2.07%
MphasiS Limited 0.63%
Transport Services  
Delhivery Limited 2.20%
Container Corporation of India Limited 1.39%
Auto Components  
CEAT Limited 1.48%
Craftsman Automation Limited 0.99%
Sona BLW Precision Forgings Limited 0.89%
Balkrishna Industries Ltd 0.11%
Gas  
Gujarat State Petronet Limited 1.83%
Indraprastha Gas Limited 1.48%
Cement & Cement Products  
JK Cement Limited 1.95%
Nuvoco Vistas Corporation Limited 1.29%
Chemicals & Petrochemicals  
Atul Limited 1.48%
Chemplast Sanmar Limited 0.78%
Sudarshan Chemical Industries Limited 0.66%
Healthcare Services  
Fortis Healthcare Limited 1.61%
Krishna Institute Of Medical Sciences Limited 1.16%
Insurance  
Max Financial Services Ltd 2.34%
Star Health And Allied Insurance Company Limited 0.41%
Telecom - Services  
Tata Communications Limited 2.50%
Power  
NTPC Ltd 2.42%
Electrical Equipment  
Thermax Limited 2.14%
Leisure Services  
The Indian Hotels Company Limited 1.05%
Westlife Foodworld Limited 1.02%
Industrial Manufacturing  
Honeywell Automation India Limited 1.75%
Tega Industries Limited 0.30%
Automobiles  
TVS Motor Company Ltd 2.00%
Fertilizers & Agrochemicals  
Bayer Cropscience Limited 1.94%
Ferrous Metals  
Jindal Steel & Power Limited 1.93%
Personal Products  
Emami Limited 1.71%
Capital Markets  
UTI Asset Management Company Limited 0.82%
HDFC Asset Management Company Limited 0.82%
Financial Technology (Fintech)  
PB Fintech Limited 1.59%
Retailing  
Trent Limited 0.82%
FSN E-Commerce Ventures Limited 0.71%
Aerospace & Defense  
Bharat Electronics Ltd 1.50%
Agricultural, Commercial & Construction Vehicles  
Ashok Leyland Limited 1.19%
Realty  
Prestige Estates Projects Limited 1.06%
Minerals & Mining  
NMDC Limited 0.83%
Textiles & Apparels  
Page Industries Ltd 0.66%
Paper, Forest & Jute Products  
JK Paper Limited 0.25%
Equity Holding Total 96.62%
Cash & Other Receivables 3.38%
Total 100.00%

Growth of Rs. 10,000 invested at inception: 23,592

Returns (in%)
1 Yr 3 Yrs SI
MAMCF 25.32% 33.66% 24.46%
Scheme Benchmark* 34.40% 34.68% 24.83%
Additional Benchmark** 23.67% 24.43% 16.13%
NAV as on 30th June, 2023 ₹ 23.592
Index Value (30th June, 2023) Index Value of Scheme benchmark is 16,791.34 and S&P BSE Sensex (TRI) is 98,623.85
Allotment Date 29 July, 2019
Scheme Benchmark *Nifty Midcap 150 (TRI)
Additional Benchmark **S&P BSE Sensex (TRI)

Fund manager : Mr. Ankit Jain managing the scheme since July, 2019
Note: Returns below or for 1 year are absolute returns, returns above 1 year are CAGR- Compounded Annualized Growth returns.

Past Performance may or may not be sustained in future. Note : For computation of since inception returns (%) the allotment NAV has been taken as ₹ 10.00. The performance of other funds managed by the same fund manager is given in the respective page of the schemes
Different Plans under the scheme has different expense structure. The reference and details provided here in are of Regular Plan - Growth Option

Period Total Amount Invested Mkt Value as on
30-June-2023
SI
4,70,000 7,46,264
3 Yrs
3,60,000 4,88,209
1 Yr
1,20,000 1,33,856

Returns (%)
Period
SI
3yrs
1yr
Fund Return& (%)
24.22 20.88 22.25
Benchmark Return& (%)
26.35 23.84 30.01
Add. Benchmark Return& (%)
17.53 15.92 18.95

& The SIP returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month.

Regular Plan
Record Date Quantum
(₹ per unit)
Face Value
(₹ per unit)
NAV
(₹ per unit)
14-Feb-23
1.75
10.00
19.17
Direct Plan
Record Date Quantum
(₹ per unit)
Face Value
(₹ per unit)
NAV
(₹ per unit)
14-Feb-23
1.70
10.00
20.22

Past Performance may or may not be sustained in future. Pursuant to payment of IDCW the NAV of the IDCW option of the scheme will fall to the extent of payout and statutory levy (if any). IDCW history is for MAMCF - Regular & Direct Plan - IDCW Option

Volatility 15.43%
Beta: 0.84
R Squared 0.86
Sharpe Ratio#: 1.73
Information Ratio -0.16
Portfolio Turnover Ratio 0.34 times

@The Volatility, Beta, R Squared, Sharpe Ratio & Information Ratio are calculated on returns from last three years Monthly data points. # Risk free rate: FBIL OVERNIGHT MIBOR as on 30th June, 2023. ^Basis last rolling 12 months.

This product is suitable for investors who are seeking*
• To generate long term capital appreciation/income.
• Investments predominantly in equity & equity related securities of midcap companies

*Investors should consult their financial advisers if they are not clear about the suitability of the product.